Exploring TNFi drug-levels and anti-drug antibodies during tapering among patients with inflammatory arthritis: secondary analyses from the randomised BIODOPT trial.
- Published in:
- Rheumatology International, 2024, v. 44, n. 10, p. 1897, doi. 10.1007/s00296-024-05665-7
- By:
- Publication type:
- Article